Clinical trial
Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations With Insulin Resistance
NCT07516509 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations With Insulin Resistance
- Lead sponsor
- AdventHealth Translational Research Institute
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 11, 2026
- Completion date
- December 31, 2028
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.